Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumors
{{output}}
Background: Chimeric antigen receptor (CAR) T cell therapy is being used to target a range of pediatric cancers. Starting materials are critical for successful CAR T cell manufacturing, most often obtained via autologous mononucl... ...
